| 臺大學術典藏 |
2021-07-05T05:42:22Z |
Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkeratosis) and oral epithelial dysplasia
|
Chiang C.-P.; Lang M.-J.; Liu B.-Y.; Wang J.-T.; Leu J.-S.; Hahn L.-J.; YEN-PING KUO |
| 臺大學術典藏 |
2021-07-05T05:42:21Z |
Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan
|
Chiang C.P.; Wu H.Y.; Liu B.Y.; Wang J.T.; YEN-PING KUO |
| 臺大學術典藏 |
2021-07-05T05:42:19Z |
High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis
|
Chiang C.P.; Hsieh R.P.; Chen T.H.H.; Chang Y.F.; Liu B.Y.; Wang J.T.; Sun A.; YEN-PING KUO |
| 臺大學術典藏 |
2021-07-05T05:42:19Z |
Sequential expressions of MMP-1, TIMP-1, IL-6, and COX-2 genes in induced periapical lesions in rats
|
Lin S-.K.; Kok S-.H.; YEN-PING KUO; Wang T-.J.; Wang J-.T.; Yeh F.T-.; Hsiao M.; Lan W.H.; Hong C-.Y. |
| 臺大學術典藏 |
2021-07-05T05:42:13Z |
Expression of hypoxia-inducible factor-1α is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan
|
Lin P.-Y.; Yu C.-H.; Wang J.-T.; Chen H.-H.; Cheng S.-J.; YEN-PING KUO; Chiang C.-P. |
| 臺大學術典藏 |
2021-07-05T05:30:52Z |
The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia
|
Fu C.-F.; Huang J.-D.; Wang J.-T.; Lin S.-W.; CHIEN-CHIH WU |
| 臺大學術典藏 |
2021-07-05T05:30:49Z |
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
|
Shao C.-H.; Tai C.-H.; Lin F.-J.; CHIEN-CHIH WU; Wang J.-T.; Wang C.-C. |
| 臺大學術典藏 |
2021-07-05T05:30:49Z |
Impact of high plasma concentrations of linezolid in Taiwanese adult patients— therapeutic drug monitoring in improving adverse drug reactions
|
Cheng C.-N.; CHIEN-CHIH WU; Kuo C.-H.; Wang C.-C.; Wang J.-T.; Lin Y.-T.; Jhang R.-S.; Lin S.-W. |
| 臺大學術典藏 |
2021-07-05T05:30:48Z |
Nephrotoxicity of teicoplanin-based combination therapy: Focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams
|
Tai C.-H.; Shao C.-H.; Wang C.-C.; Lin F.-J.; Wang J.-T.; CHIEN-CHIH WU |
| 臺大學術典藏 |
2021-07-05T01:12:13Z |
Impact of high plasma concentrations of linezolid in Taiwanese adult patients— therapeutic drug monitoring in improving adverse drug reactions
|
Cheng C.-N.; Wu C.-C.; Kuo C.-H.; CHI-CHUAN WANG; Wang J.-T.; Lin Y.-T.; Jhang R.-S.; Lin S.-W. |
| 臺大學術典藏 |
2021-07-05T01:12:12Z |
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
|
Shao C.-H.; Tai C.-H.; Lin F.-J.; Wu C.-C.; Wang J.-T.; CHI-CHUAN WANG |
| 臺大學術典藏 |
2021-07-03T03:36:30Z |
Hepatitis C virus infection in Taiwan
|
Chen D.-S.; Wang J.-T.; PEI-JER CHEN; Wang T.-H.; Sung J.-L. |
| 臺大學術典藏 |
2021-07-03T03:36:25Z |
Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV.
|
Lin H.H.; Hsu H.Y.; Chang M.H.; Wang J.T.; PEI-JER CHEN; Chen D.S. |
| 臺大學術典藏 |
2021-07-03T03:36:25Z |
Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: Putative serological marker for acute viral infection
|
PEI-JER CHEN; Wang J.-T.; Hwang L.-H.; Yang Y.-H.; Hsieh C.-L.; Kao J.-H.; Sheu J.-C.; Lai M.-Y.; Wang T.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:36:17Z |
Transfusion-transmitted human T-cell lymphotropic virus type I infection in Taiwan: A true risk and occasional coinfection with hepatitis C virus shown in a prospective study
|
Wang J.-T.; Lin M.-T.; PEI-JER CHEN; Sheu J.-C.; Lin J.-T.; Wang T.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:36:10Z |
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C
|
Lai M.-Y.; Kao J.-H.; Yang P.-M.; Wang J.-T.; PEI-JER CHEN; Chan K.-W.; Chu J.- S.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:36:09Z |
Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein
|
Hwang L.-H.; Yang P.-M.; Lai M.-Y.; Chiang B.-L.; Kao J.-H.; Wang J.-T.; Lee S.-Y.; Chian H.-M.; Chi W.-K.; Chu Y.-D.; PEI-JER CHEN; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:36:08Z |
A prospective study of transfusion-transmitted GB virus C infection: Similar frequency but different clinical presentation compared with hepatitis C virus
|
Wang J.-T.; Tsai F.-C.; Lee C.-Z.; PEI-JER CHEN; Sheu J.-C.; Wang T.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:36:07Z |
GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer
|
Kao J.-H.; PEI-JER CHEN; Lai M.-Y.; Chen W.; Liu D.-P.; Wang J.-T.; Shen M.- C.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:36:07Z |
Superinfection by homotypic virus in hepatitis C virus carriers: Studies on patients with post-transfusion hepatitis
|
Kao J.H.; PEI-JER CHEN; Wang J.T.; Yang P.M.; Lai M.Y.; Wang T.H.; Chen D.S. |
| 臺大學術典藏 |
2021-07-03T03:36:06Z |
Blood-bank screening for hepatitis G [14]
|
Kao J.-H.; PEI-JER CHEN; Wang J.-T.; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:36:03Z |
Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan
|
Wang J.-T.; PEI-JER CHEN; Liu D.-P.; Sheu J.-C.; Wang T.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:35:49Z |
Transfusion-transmitted HBV infection in an endemic area: The necessity of more sensitive screening for HBV carriers
|
Wang J-.T.; Lee C-.Z.; PEI-JER CHEN; Wang T-.H.; Chen D-.S. |
| 臺大學術典藏 |
2021-07-03T03:35:39Z |
Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan
|
Hsueh P.-R.; Hsiao C.-H.; Yeh S.-H.; Wang W.-K.; PEI-JER CHEN; Wang J.-T.; Chang S.-C.; Kao C.-L.; Yang P.-C.; Chen D.-S.; Lee Y.-T.; Teng C.-M.; Ho H.-N.; Chang M.-F. |
| 臺大學術典藏 |
2021-07-03T03:35:37Z |
Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002
|
Chang L.-Y.; Chang I.-S.; Lu C.-Y.; Chiang B.-L.; Lee C.-Y.; PEI-JER CHEN; Wang J.-T.; Ho H.-N.; Chen D.-S.; Huang L.-M. |
